---
title: "anagliptin - Diabetes mellitus type 2"
sidebar: mydoc_sidebar
permalink: anagliptindiabetesmellitustype2.html
toc: false 
---

{% include image.html url="images/anagliptindiabetesmellitustype2.png" file="anagliptindiabetesmellitustype2.png" alt="anagliptindiabetesmellitustype2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C583175 | anagliptin | Drug |
| UniProt:P27487 | Dipeptidyl peptidase 4 | Protein |
| CHEBI:80270 | Glucagon-like peptide 1 | ChemicalSubstance |
| GO:0030073 | insulin secretion | BiologicalProcess |
| GO:0070091 | glucagon secretion | BiologicalProcess |
| HP:0003074 | Hyperglycemia | PhenotypicFeature |
| MESH:D003924 | Diabetes mellitus type 2 | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Anagliptin | DECREASES ACTIVITY OF | Dipeptidyl Peptidase 4 |
| Dipeptidyl Peptidase 4 | DECREASES ABUNDANCE OF | Glucagon-Like Peptide 1 |
| Glucagon-Like Peptide 1 | POSITIVELY REGULATES | Insulin Secretion |
| Glucagon-Like Peptide 1 | NEGATIVELY REGULATES | Glucagon Secretion |
| Insulin Secretion | NEGATIVELY REGULATES | Hyperglycemia |
| Glucagon Secretion | POSITIVELY CORRELATED WITH | Hyperglycemia |
| Hyperglycemia | MANIFESTATION OF | Diabetes Mellitus Type 2 |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB12417#mechanism-of-action](https://go.drugbank.com/drugs/DB12417#mechanism-of-action){:target="_blank"}